Results 11 to 20 of about 36,896 (275)

Intraocular pressure variability in patients who reached target intraocular pressure [PDF]

open access: yesBritish Journal of Ophthalmology, 2005
To assess the intraocular pressure (IOP) variability in patients with primary open angle glaucoma (POAG) under clinical treatment who reached an established target pressure based on isolated office readings.Retrospective analysis of 65 eyes from 65 POAG patients under clinical therapy who submitted to modified diurnal tension curve (mDTC) (measurements
F K, Malerbi   +3 more
openaire   +2 more sources

CORRELATIONS BETWEEN SUCCESSFUL THERAPY AND ANXIETY LEVEL OF POST OPERATIVE GLAUCOMA PATIENTS

open access: yesJurnal Kedokteran Diponegoro, 2020
Background : Glaucoma is a disease that can cause damage to the optic nerve. High intraocular pressure is a major risk factor for glaucoma. The main goal of treating glaucoma is to control the disease progression by reducing intraocular pressure to the ...
Singgih Pratama   +3 more
doaj   +1 more source

Intraocular pressure reduction in glaucoma: Does every mmHg count?

open access: yesTaiwan Journal of Ophthalmology, 2020
The reduction of intraocular pressure is currently the only known modifiable risk factor for the treatment of Glaucoma, which is the leading cause of irreversible worldwide blindness.
Hari Jayaram
doaj   +1 more source

Long-term medication reduction in controlled glaucoma with iTrack ab-interno canaloplasty as a standalone procedure and combined with cataract surgery

open access: yesTherapeutic Advances in Ophthalmology, 2021
Purpose: To evaluate the long-term effectiveness of iTrack (Nova Eye Medical, Fremont, USA) ab-interno canaloplasty performed as a standalone procedure, or combined with cataract surgery, in reducing antiglaucoma medication dependence and maintaining ...
Mahmoud A. Khaimi
doaj   +1 more source

Pharmacodynamic equivalence study of two preparations of eye drops, containing dorzolamide in healthy volunteers [PDF]

open access: yesHospital Pharmacology, 2016
Introduction: Dorzolamide 20mg/ml eye drops (dorzolamide hydrochloride (CAS: 120279-96-1)) is a topical carbonic anhydrase inhibitor indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular ...
Gatchev Emil M.   +6 more
doaj   +1 more source

Evaluation of filtering blebs using the ‘Wuerzburg bleb classification score’ compared to clinical findings

open access: yesBMC Ophthalmology, 2012
Background To determine the agreement between intraocular pressure and the ‘Wuerzburg bleb classification score’, as well as between single items of the score and intraocular pressure. Interobserver variability was analyzed.
Furrer Sandra   +3 more
doaj   +1 more source

Systems genetics identifies a role for Cacna2d1 regulation in elevated intraocular pressure and glaucoma susceptibility [PDF]

open access: yes, 2017
Glaucoma is a multi-factorial blinding disease in which genetic factors play an important role. Elevated intraocular pressure is a highly heritable risk factor for primary open angle glaucoma and currently the only target for glaucoma therapy.
Allingham, R. (Rand)   +62 more
core   +1 more source

Implantable micromechanical parylene-based pressure sensors for unpowered intraocular pressure sensing [PDF]

open access: yes, 2007
This paper presents the first implantable, unpowered, parylene-based microelectromechanical system (MEMS) pressure sensor for intraocular pressure (IOP) sensing.
Agrawal, Rajat   +7 more
core   +1 more source

Canaloplasty in the Treatment of Open-Angle Glaucoma: A Review of Patient Selection and Outcomes. [PDF]

open access: yes, 2018
Canaloplasty is a relatively new non-penetrating surgery for the reduction of intraocular pressure in patients affected by glaucoma. The technique uses a microcatheter to perform a 360 º cannulation of Schlemm's canal and leaves in place a tension suture
Brusini, Paolo   +5 more
core   +2 more sources

Biomechanical, ultrastructural, and electrophysiological characterization of the non-human primate experimental glaucoma model. [PDF]

open access: yes, 2017
Laser-induced experimental glaucoma (ExGl) in non-human primates (NHPs) is a common animal model for ocular drug development. While many features of human hypertensive glaucoma are replicated in this model, structural and functional changes in the ...
Christian, Brian J   +11 more
core   +2 more sources

Home - About - Disclaimer - Privacy